369 related articles for article (PubMed ID: 32969759)
1. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
[No Abstract] [Full Text] [Related]
2. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives.
Bhatt M; Peshkin BN; Kazi S; Schwartz MD; Ashai N; Swain SM; Smith DM
Pharmacogenomics; 2023 Nov; 24(16):859-870. PubMed ID: 37942634
[No Abstract] [Full Text] [Related]
4. Attitudes about pharmacogenomic testing vary by healthcare specialty.
Preys CL; Blout Zawatsky CL; Massmann A; Heukelom JV; Green RC; Hajek C; Hickingbotham MR; Zoltick ES; Schultz A; Christensen KD
Pharmacogenomics; 2023 Jul; 24(10):539-549. PubMed ID: 37458095
[No Abstract] [Full Text] [Related]
5. Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study.
Dressler LG; Bell GC; Abernathy PM; Ruch K; Denslow S
Pharmacogenomics; 2019 Apr; 20(6):433-446. PubMed ID: 30983513
[No Abstract] [Full Text] [Related]
6. Pharmacogenomics: Prescribing Precisely.
Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
[TBL] [Abstract][Full Text] [Related]
7. Primary care physicians' knowledge of and experience with pharmacogenetic testing.
Haga SB; Burke W; Ginsburg GS; Mills R; Agans R
Clin Genet; 2012 Oct; 82(4):388-94. PubMed ID: 22698141
[TBL] [Abstract][Full Text] [Related]
8. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
[TBL] [Abstract][Full Text] [Related]
9. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
[No Abstract] [Full Text] [Related]
10. Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.
Liko I; Corbin L; Tobin E; Aquilante CL; Lee YM
Am J Health Syst Pharm; 2021 Jun; 78(12):1094-1103. PubMed ID: 33772264
[TBL] [Abstract][Full Text] [Related]
11. Patient perspectives following pharmacogenomics results disclosure in an integrated health system.
Lemke AA; Hulick PJ; Wake DT; Wang C; Sereika AW; Yu KD; Glaser NS; Dunnenberger HM
Pharmacogenomics; 2018 Mar; 19(4):321-331. PubMed ID: 29469671
[TBL] [Abstract][Full Text] [Related]
12. Assessment and clinical utility of pharmacogenomics by healthcare practitioners in North Carolina.
Raccor BS; Thompson DK; Thomas C; Hill AK; Shields K; Alcala-Williams I; Cartrette T; Fasinu P; Al-Achi A
Pharmacogenomics; 2021 Jan; 22(1):13-25. PubMed ID: 33356552
[No Abstract] [Full Text] [Related]
13. Primary care provider perceptions and experiences of implementing hepatitis C virus birth cohort testing: a qualitative formative evaluation.
Yakovchenko V; Bolton RE; Drainoni ML; Gifford AL
BMC Health Serv Res; 2019 Apr; 19(1):236. PubMed ID: 31014322
[TBL] [Abstract][Full Text] [Related]
14. Results of a nationwide survey of Japanese pharmacists regarding the application of pharmacogenomic testing in precision medicine.
Tsuji D; Saito Y; Mushiroda T; Miura M; Hira D; Terada T
J Clin Pharm Ther; 2021 Jun; 46(3):649-657. PubMed ID: 33555613
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
[No Abstract] [Full Text] [Related]
16. Provider attitudes and practice patterns of obesity management with pharmacotherapy.
Granara B; Laurent J
J Am Assoc Nurse Pract; 2017 Sep; 29(9):543-550. PubMed ID: 28665500
[TBL] [Abstract][Full Text] [Related]
17. Provider Perspectives of Patient Experiences in Primary Care Imaging.
Zigman Suchsland ML; Hardy V; Zhang Y; Vigil PD; Collins KL; Woodhouse WM; Chou R; Findlay SD; Lavallee DC; Thompson MJ
J Am Board Fam Med; 2019; 32(3):392-397. PubMed ID: 31068403
[TBL] [Abstract][Full Text] [Related]
18. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization.
Bar-Peled Y; Denton JJ; Richards JL; Brown D; Worthey E; Strong TV
Pharmacogenomics; 2024 Mar; 25(4):207-216. PubMed ID: 38506331
[No Abstract] [Full Text] [Related]
20. Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions.
Hoffecker G; Kanter GP; Xu Y; Matthai W; Kolansky DM; Giri J; Tuteja S
Per Med; 2022 Jan; 19(1):41-49. PubMed ID: 34881641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
